The guidance published on 25 Jul 2008 related to the 1H 2008 results estimated revenue of RMB 230 mln, which represents a 15.09% decrease from a year earlier, together with net profit of RMB 769,800, representing a YOY decrease of 60.17%. The company asserted that the decrease in revenue for 1H 2008 was caused by a RMB 55,582,700 drop in its sales of pharmaceutical ingredients.

Source: Securities Times

Date: 25 Jul 2008

CN01/NW/SW/BT/MM